Syncell
Syncell develops next-generation subcellular protein purification and spatial proteomics analysis technology. Their Microscoop platform enables high-precision, unbiased spatial proteomic discovery, helping researchers identify disease biomarkers and drug targets. This technology is applicable across various research areas, including oncology and neurodegenerative diseases.
Funding Round: Series A
Funding Amount: $15M
Date: 11-Dec-2024
Investors: Taiwan Capital
Markets: Life Sciences, Biotechnology, Proteomics, Spatial Biology
HQ: Taipei, Taiwan, Taiwan
Founded: 2020
Website: https://syncell.com
LinkedIn: https://www.linkedin.com/company/syncell/
Twitter: https://twitter.com/SyncellInc
Facebook: https://www.facebook.com/profile.php?id=61569986517126
Crunchbase: https://www.crunchbase.com/organization/syncell
Leave a Comment
Comments
No comments yet.